Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 4856761, 10 pages
http://dx.doi.org/10.1155/2016/4856761
Research Article

Astragalus Polysaccharide Suppresses 6-Hydroxydopamine-Induced Neurotoxicity in Caenorhabditis elegans

1Center for Bioresources & Drug Discovery and School of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
2Research & Development Center, Infinitus (China) Company Ltd., Guangzhou 510665, China
3Guangdong Province Key Laboratory for Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou 510006, China

Received 17 June 2016; Revised 19 September 2016; Accepted 13 October 2016

Academic Editor: Renata Szymanska

Copyright © 2016 Haifeng Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. G. Ondo, “Motor complications in Parkinson's disease,” International Journal of Neuroscience, vol. 121, no. 2, pp. 37–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Coelho and J. J. Ferreira, “Late-stage Parkinson disease,” Nature Reviews Neurology, vol. 8, no. 8, pp. 435–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Pringsheim, N. Jette, A. Frolkis, and T. D. L. Steeves, “The prevalence of Parkinson's disease: a systematic review and meta-analysis,” Movement Disorders, vol. 29, no. 13, pp. 1583–1590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Hellqvist and C. Berterö, “Support supplied by Parkinson's disease specialist nurses to Parkinson's disease patients and their spouses,” Applied Nursing Research, vol. 28, no. 2, pp. 86–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Bellou, L. Belbasis, I. Tzoulaki, E. Evangelou, and J. P. A. Ioannidis, “Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses,” Parkinsonism & Related Disorders, vol. 23, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Bové and C. Perier, “Neurotoxin-based models of Parkinson's disease,” Neuroscience, vol. 211, pp. 51–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Segura-Aguilar and R. M. Kostrzewa, “Neurotoxin mechanisms and processes relevant to Parkinson’s disease: an update,” Neurotoxicity Research, vol. 27, no. 3, pp. 328–354, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Wang, F. Yang, W. Guo et al., “Caenorhabditis elegans in Chinese medicinal studies: Making the case for aging and neurodegeneration,” Rejuvenation Research, vol. 17, no. 2, pp. 205–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Nass, M. K. Hahn, T. Jessen, P. W. McDonald, L. Carvelli, and R. D. Blakely, “A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking,” Journal of Neurochemistry, vol. 94, no. 3, pp. 774–785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Fu, Z. Wang, L. Huang et al., “Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi),” Phytotherapy Research, vol. 28, no. 9, pp. 1275–1283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Zhang, N. Pan, S. Xiong et al., “Inhibition of polyglutamine-mediated proteotoxicity by Astragalus membranaceus polysaccharide through the DAF-16/FOXO transcription factor in Caenorhabditis elegans,” Biochemical Journal, vol. 441, no. 1, pp. 417–424, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. W.-X. Li, S.-G. Sun, H. Yuan, H.-T. Wang, Y.-B. Zhang, and B.-L. Sun, “Time dependency of astragalus polysaccharides against systemic injury of free radical in astrocyte culture medium,” Chinese Journal of Clinical Rehabilitation, vol. 10, no. 11, pp. 59–61, 2006. View at Google Scholar · View at Scopus
  13. P. Newland, B. Bingham, E. Tarelli, and A. H. Thomas, “High-performance gel permeation chromatography of meningococcal polysaccharides,” Journal of Chromatography A, vol. 483, pp. 406–412, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Huang, Y. Liu, B. S. Paulsen, and D. Klaveness, “Studies on polysaccharides from three edible species of Nostoc (Cyanobacteria) with different colony morphologies: Comparison of monosaccharide compositions and viscosities of polysaccharides from field colonies and suspension cultures,” Journal of Phycology, vol. 34, no. 6, pp. 962–968, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. S. W. Emmons, M. R. Klass, and D. Hirsh, “Analysis of the constancy of DNA sequences during development and evolution of the nematode Caenorhabditis elegans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 3, pp. 1333–1337, 1979. View at Publisher · View at Google Scholar · View at Scopus
  16. R.-H. Fu, H.-J. Harn, S.-P. Liu et al., “n-Butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease,” PLoS ONE, vol. 9, no. 1, article e85305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. Wang, Y. Huang, C. Qin et al., “Bioactive peptides from Angelica sinensis protein hydrolyzate delay senescence in Caenorhabditis elegans through antioxidant activities,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8956981, 10 pages, 2016. View at Publisher · View at Google Scholar
  18. S. Shashikumar, H. Pradeep, S. Chinnu, P. S. Rajini, and G. K. Rajanikant, “Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans,” Physiology & Behavior, vol. 151, pp. 563–569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Suo, S. Ishiura, and H. H. M. Van Tol, “Dopamine receptors in C. elegans,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 159–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Tucci, A. J. Harrington, G. A. Caldwell, and K. A. Caldwell, “Modeling dopamine neuron degeneration in Caenorhabditis elegans,” Methods in Molecular Biology, vol. 793, pp. 129–148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Chen, A. G. Kanthasamy, and M. B. Reddy, “EGCG protects against 6-OHDA-induced neurotoxicity in a cell culture model,” Parkinson's Disease, vol. 2015, Article ID 843906, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Jin, K. Zhao, Q. Huang, and P. Shang, “Structural features and biological activities of the polysaccharides from Astragalus membranaceus,” International Journal of Biological Macromolecules, vol. 64, pp. 257–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Sun, K. Zheng, H. Zhao et al., “Regulatory effect of astragalus polysaccharides on intestinal intraepithelial γδT cells of tumor bearing mice,” Molecules, vol. 19, no. 9, pp. 15224–15236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Yang, B. Xiao, and T. Sun, “Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice,” International Journal of Biological Macromolecules, vol. 62, pp. 287–290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Luo, J. Qin, M. Liu et al., “Astragalus polysaccharide attenuates lipopolysaccharide-induced inflammatory responses in microglial cells: regulation of protein kinase B and nuclear factor-κB signaling,” Inflammation Research, vol. 64, no. 3-4, pp. 205–212, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Dansokho, D. Ait Ahmed, S. Aid et al., “Regulatory T cells delay disease progression in Alzheimer-like pathology,” Brain, vol. 139, no. 4, pp. 1237–1251, 2016. View at Publisher · View at Google Scholar
  27. C.-W. Hung, Y.-C. Chen, W.-L. Hsieh, S.-H. Chiou, and C.-L. Kao, “Ageing and neurodegenerative diseases,” Ageing Research Reviews, vol. 9, pp. S36–S46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Xu, W.-F. Chen, and M.-S. Wong, “Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway,” British Journal of Pharmacology, vol. 158, no. 3, pp. 738–748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Nikam, P. Nikam, S. K. Ahaley, and A. V. Sontakke, “Oxidative stress in Parkinson's disease,” Indian Journal of Clinical Biochemistry, vol. 24, no. 1, pp. 98–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. L. Albarracin, B. Stab, Z. Casas et al., “Effects of natural antioxidants in neurodegenerative disease,” Nutritional Neuroscience, vol. 15, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Li, P. Wang, Z. Yu et al., “The effect of creatine and coenzyme Q10 combination therapy on mild cognitive impairment in Parkinson's disease,” European Neurology, vol. 73, no. 3-4, pp. 205–211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Matés, “Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology,” Toxicology, vol. 153, no. 1–3, pp. 83–104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. In, C.-W. Hong, B. Choi, B.-G. Jang, and M.-J. Kim, “Inhibition of mitochondrial clearance and Cu/Zn-SOD activity enhance 6-hydroxydopamine-induced neuronal apoptosis,” Molecular Neurobiology, vol. 53, no. 1, pp. 777–791, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Pu, X. Ma, L. Liu et al., “Structural characterization and antioxidant activity in vitro of polysaccharides from angelica and astragalus,” Carbohydrate Polymers, vol. 137, pp. 154–164, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Xue, F. Gan, Z. Zhang, J. Hu, X. Chen, and K. Huang, “Astragalus polysaccharides inhibits PCV2 replication by inhibiting oxidative stress and blocking NF-κB pathway,” International Journal of Biological Macromolecules, vol. 81, pp. 22–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. L. del Peso, V. M. González, and G. Núnez, “Caenorhabditis elegans EGL-1 disrupts the interaction of CED-9 with CED-4 and promotes CED-3 activation,” The Journal of Biological Chemistry, vol. 273, no. 50, pp. 33495–33500, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Nass, D. H. Hall, D. M. Miller III, and R. D. Blakely, “Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 3264–3269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Pu and W. Le, “Dopamine neuron degeneration induced by MPP+ is independent of CED-4 pathway in Caenorhabditis elegans,” Cell Research, vol. 18, no. 9, pp. 978–981, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. O. J. Olatunji, Y. Feng, O. O. Olatunji, J. Tang, Z. Ouyang, and Z. Su, “Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties,” Biomedicine & Pharmacotherapy, vol. 81, pp. 7–14, 2016. View at Publisher · View at Google Scholar
  40. H. Qian, X. Xu, and L. E. Niklason, “Bmk-1 regulates lifespan in Caenorhabditis elegans by activating hsp-16,” Oncotarget, vol. 6, no. 22, pp. 18790–18799, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. K.-J. Yin, C. Y. Hsu, X.-Y. Hu et al., “Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-β peptide-induced cerebrovascular endothelial cell death,” The Journal of Neuroscience, vol. 26, no. 8, pp. 2290–2299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Genestra, “Oxyl radicals, redox-sensitive signalling cascades and antioxidants,” Cellular Signalling, vol. 19, no. 9, pp. 1807–1819, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Son, S. Kim, H.-T. Chung, and H.-O. Pae, “Reactive oxygen species in the activation of MAP kinases,” Methods in Enzymology, vol. 528, pp. 27–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Cao, Y. Ruan, T. Shen et al., “Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 674219, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Cui, N. Cui, P. Wang, S. Song, H. Liang, and A. Ji, “Neuroprotective effect of sulfated polysaccharide isolated from sea cucumber Stichopus japonicus on 6-OHDA-induced death in SH-SY5Y through inhibition of MAPK and NF-κB and activation of PI3K/Akt signaling pathways,” Biochemical and Biophysical Research Communications, vol. 470, no. 2, pp. 375–383, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Aosaki, M. Miura, T. Suzuki, K. Nishimura, and M. Masuda, “Acetylcholine-dopamine balance hypothesis in the striatum: an update,” Geriatrics & Gerontology International, vol. 10, supplement 1, pp. S148–S157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. N. I. Bohnen and R. L. Albin, “The cholinergic system and Parkinson disease,” Behavioural Brain Research, vol. 221, no. 2, pp. 564–573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Jospin, Y. B. Qi, T. M. Stawicki et al., “A neuronal acetylcholine receptor regulates the balance of muscle excitation and inhibition in Caenorhabditis elegans,” PLoS Biology, vol. 7, no. 12, article e1000265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. T. A. Slotkin, I. T. Ryde, N. Wrench, J. A. Card, and F. J. Seidler, “Nonenzymatic role of acetylcholinesterase in neuritic sprouting: regional changes in acetylcholinesterase and choline acetyltransferase after neonatal 6-hydroxydopamine lesions,” Neurotoxicology and Teratology, vol. 31, no. 3, pp. 183–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. B.-Q. Zhang, S.-J. Hu, L.-H. Qiu et al., “Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine,” Vascular Pharmacology, vol. 46, no. 4, pp. 278–285, 2007. View at Publisher · View at Google Scholar · View at Scopus